Statement on Second Circuit Order Upholding “Pharma Bro” Martin Shkreli’s Lifetime Ban
Bureau of Competition Director Henry Liu issued the following statement on the Second Circuit’s order:
- Bureau of Competition Director Henry Liu issued the following statement on the Second Circuit’s order:
“The Second Circuit’s decision is a win for consumers seeking affordable, lifesaving medication and clearly demonstrates that corporate executives will be held personally liable for anticompetitive actions that they help orchestrate. - The Court imposed a lifetime ban against Shkreli participating in the pharmaceutical industry and found Shkreli liable for $64.6 million in disgorgement.
- The Federal Trade Commission works to promote competition, and protect and educate consumers.
- For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.